期刊文献+

辛伐他汀对SMMC-7721的凋亡作用及机制研究 被引量:1

下载PDF
导出
摘要 他汀类药物是治疗高脂血症的药物,近年的研究表明他汀类药物具有抗肿瘤作用。研究显示他汀类药物可诱导乳腺癌,结肠癌等肿瘤细胞的凋亡。本实验以人肝癌细胞SMMC-7721为研究对象,观察辛伐他汀对肝癌细胞凋亡的影响,并初步探讨其作用机制。
作者 杨士杰 姜达
出处 《河北医药》 CAS 2012年第4期591-592,共2页 Hebei Medical Journal
  • 相关文献

参考文献11

  • 1周永,糜漫天,张乾勇,郎海滨.胆固醇抑制剂洛伐他汀对MCF-7细胞增殖分化功能及形态结构的影响[J].肿瘤防治研究,2003,30(3):210-213. 被引量:3
  • 2:hristophe D,'Marc V,Marie K,et al. Cerivastatin,an inhibitor of HMG CoA reduetase,inhibits the signaling pathways involved in the invasivekess and metastatic properties of highly invasive breast cancer cell lines : Ln in vitro study. Carcinogenesis,2001,22 : 1139-1148.
  • 3Banke A, Sanjay B, Balasz H, et al. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clinical Cancer Research, 1999,5:2223-2229.
  • 4Wojciech F, Izabeta Y, Ewa Z, et al. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of Dox0rubicin in three tumor models in mice. Clinical Cancer Research ,2000,6:2044-2052.
  • 5Vega GL, Weiner MF, Lipton AM, et al. Reduction in Levels of 24S- Hydroxycholesterol by Statin treatment in Patiens with Alzhei mer disease. Arch Neurol,60,510-515.
  • 6Youssef S, Stuve D, Patarroyo PJ, et al. The HMG-CoA reductase inhibitor,atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002,420:78 -84.
  • 7Narisawa T, Morotomi M, Fukaura Y, et 81. Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of Nmethyl,N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res, 1996,87:988.
  • 8张明,姜达.他汀类药物在抗肿瘤中的研究进展[J].肿瘤防治研究,2004,31(11):714-717. 被引量:6
  • 9Marco R, Lorenzo A, Paul M, et al. Pharmacological control of the meval- onate pathway:effect on arterial smooth muscle cell proliferation. JPET, 1997,3:1144-1153.
  • 10Kelvin K,Chan W,Amit M,et al. The Statins as Anticancer Agents, Clinical Cancer Research ,2003,9 : 10-19.

二级参考文献21

  • 1Feleszko W,Zagozdzon R,Golab J,et al. Potentiated antitumor effects of cisplatin and lovastatin against MmB16 melanoma in mice[J].Eur J Cancer, 1998,34(3):406-411.
  • 2Matar P,Rozados VR,Roggero EA,et al. Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma[J].Cancer-Biother-Radiopharm,1998,13(5):387-393.
  • 3Li HY,Appelbaum FR,Willman CL,et al.Cholesterd-modulating agents kill acute myeloid leukemia cells and sensitize them to therpentics by blocking adaptive cholesterd responses[J].Blood,2003,101(9):3628-3634.
  • 4Mueck AO,Seeger H,Wallwiener D. Effect of statins combined with estraiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells[J].Menopause, 2003,10(4):332-336.
  • 5Banke Agarwal,Balazs Halmos,Aleksander S, et al.Mechanism of lovastatin-induced apotosis in intesnalepithelial cells[J].Carcinogenesis,2002,23(3):521-528.
  • 6Farina HG,Bublik DR,Alonso DF,et al. Lovastatin alters cytoskleton organization and inhibits experimental metastasis of mammary carcinoma cells[J].Clin-Exp-Metastasis,2002,19(6):551-559.
  • 7Christophe Denoyelle,Marc Vasse,Marie Korner,et al. Cerivastatin,an inhibitor of HMG-CoA reductase,inhibits the signaling pathways invoved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:an in vitro study[J].Carci
  • 8Zukerbraum BS,Shapiro RA,Billiar TR,et al.RhoA influences the nuclear location of extracellular signal-regulated kinases to modulate p21Waf/Cipl expression[J].Circulation,2003,108(7):876-881.
  • 9Cross TG, Scheel-Toelner D,Henriquez NV,et al. Sreine/threonine protein kinases and apoptosis[J].Exp Cell Res,2000,256(1):34-41.
  • 10Holmstrom TH,Schmitz I,Soderstrom TS, et al, MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptasis downstream of DISC assembly[J].EMBO.J,2000,19(20):5418-5428.

共引文献7

同被引文献20

  • 1肖胤,杨军,肖林,王涛.Survivin基因在人涎腺腺样囊性癌中的表达[J].临床口腔医学杂志,2007,23(4):209-211. 被引量:14
  • 2Schoenfeld JD, Sher DJ, Norris CM Jr, et al. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy [J]. Int J Radiat Oncol Biol Phys, 2012, 82(1): 308-314.
  • 3Shen C, Xu T, Huang C, et al. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck [J]. Oral Oncol, 2012, 48(5): 445-449.
  • 4Borahay MA, Kilic GS, Yallampalli C, et al. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells [J]. J Biol Chem, 2014, 289(51): 35075-35086.
  • 5Lee KJ, Moon JY, Choi HK, et al. Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance [J]. Clin Exp Immunol, 2010, 161(2): 298-305.
  • 6Chang HL, Chen CY, Hsu YF, et al. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade[J]. Biochim Biophys Acta, 2013, 1830(8): 4053-4064.
  • 7Otsuki T, Kanno T, Fujita Y, et al. A3 adenosine receptor-mediated p53-dependent apoptosis in Lu-65 human lung cancer cells [J]. Cell Physiol Biochem, 2012, 30(1): 210-220.
  • 8Shankar SL, Mani S, O'guin KN, et al. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways[J]. J Neurochem, 2001, 79(2): 426-436.
  • 9Wang Y, Xu SL, Wu YZ, et al. Simvastatin induces caspase-dependent apoptosis and activates P53 in OCM-1 cells[J]. Exp Eye Res, 2013, 113: 128-134.
  • 10Chan KK, Oza AM, Siu LL. The statins as anticancer agents [J]. Clin Cancer Res, 2003, 9(1): 10-19.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部